Document is current
Any future updates will be listed below
-
Authors
Vickovic, Sanja https://orcid.org/0000-0003-0985-9885
Schapiro, Denis https://orcid.org/0000-0002-9391-5722
Carlberg, Konstantin https://orcid.org/0000-0002-1774-6058
Lötstedt, Britta
Larsson, Ludvig https://orcid.org/0000-0003-4209-2911
Hildebrandt, Franziska
Korotkova, Marina
Hensvold, Aase H.
Catrina, Anca I.
Sorger, Peter K. https://orcid.org/0000-0002-3364-1838
Malmström, Vivianne https://orcid.org/0000-0001-9251-8082
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Ståhl, Patrik L. https://orcid.org/0000-0002-2207-7370
-
Funding
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (2017.0454)
Svenska Sällskapet för Medicinsk Forskning (P19-0052)
Royal Swedish Academy of Sciences (BS2019-0040)
- License Information
-
More Information
Article History
Received: 23 December 2020
Accepted: 10 January 2022
First Online: 11 February 2022
Competing interests
: S.V and P.L.S. are authors on patents applied for by Spatial Transcriptomics AB (10× Genomics Inc.) covering the technology. D.S. is a scientific consultant to Roche Glycart AG. P.L.S. and K.C. are scientific consultants to 10× Genomics Inc. P.K.S. is on the SAB or BOD of Rarecyte Inc., Applied Biomath LLC, Glencoe Software Inc. and Nanostring Inc.; none of these relationships are directly related to the topic of this study. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and until August 31, 2020 was an SAB member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov, and ThermoFisher Scientific. From August 1, 2020, A.R. is an employee of Genentech, a member of the Roche Group. S.V. and A.R. are co-inventors on PCT/US2020/015481 relating to this work. All other authors declare no competing interests.
